GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Retained Earnings

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Retained Earnings : ¥35,740 Mil (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Jiangsu Hengrui Pharmaceuticals Co's retained earnings for the quarter that ended in Mar. 2025 was ¥35,740 Mil.

Jiangsu Hengrui Pharmaceuticals Co's quarterly retained earnings increased from Sep. 2024 (¥32,149 Mil) to Dec. 2024 (¥33,866 Mil) and increased from Dec. 2024 (¥33,866 Mil) to Mar. 2025 (¥35,740 Mil).

Jiangsu Hengrui Pharmaceuticals Co's annual retained earnings increased from Dec. 2022 (¥25,520 Mil) to Dec. 2023 (¥28,803 Mil) and increased from Dec. 2023 (¥28,803 Mil) to Dec. 2024 (¥33,866 Mil).


Jiangsu Hengrui Pharmaceuticals Co Retained Earnings Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Retained Earnings Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,844.23 22,873.12 25,520.21 28,802.77 33,865.53

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30,171.70 30,960.75 32,148.58 33,865.53 35,739.59

Jiangsu Hengrui Pharmaceuticals Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Jiangsu Hengrui Pharmaceuticals Co  (SHSE:600276) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Jiangsu Hengrui Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
Executives
Zhang Lian Shan Directors, senior managers
Sun Xu Gen senior management
Yuan Kai Hong senior management
Zou Jian Jun senior management
senior management
Zhang Yue Hong senior management
Liu Xiao Han senior management
Zhou Yun Shu Directors, senior managers
Liao Cheng senior management
Wang Hong Sen senior management
Zhou Song senior management
Tao Wei Kang senior management
Jiang Su Mei senior management
Dai Hong Bin Directors, senior managers
Sun Jie Ping Directors, senior managers

Jiangsu Hengrui Pharmaceuticals Co Headlines

No Headlines